Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/107671

In Collections

This item can be found in the following collections:

Reichardt, P.; Joensuu, H.; Casali, P.G.; Kang, Y.K.; Blay, J.Y.; Rutkowski, P.; ... ; Demetri, G.D. (2014)

Results from a phase III trial (GRID) evaluating regorafenib (REG) in metastatic gastrointestinal stromal tumour (GIST): Subgroup analysis of outcomes based on pretreatment characteristics

Article / Letter to editor
All authors
Reichardt, P.; Joensuu, H.; Casali, P.G.; Kang, Y.K.; Blay, J.Y.; Rutkowski, P.; Gelderblom, H.; Hohenberger, P.; Leahy, M.G.; Mehren, M. von; Badalamenti, G.; Blackstein, M.E.; Cesne, A. le; Schoffski, P.; Maki, R.G.; Xu, J.M.; Nishida, T.; Kappeler, C.; Kuss, I.; Demetri, G.D.
Date
2014-02-28
Journal
Oncology Research and Treatment
Volume
37
Pages
57 - 57